ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for INVA

Stock NameInnoviva Inc
TickerINVA(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS45781M1018
LEI549300ACOX4QTBES6535

Show aggregate INVA holdings

News associated with INVA

Innoviva (NASDAQ:INVA) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen upgraded shares of Innoviva (NASDAQ:INVA – Free Report) from a buy rating to a strong-buy rating in a report released on Monday morning. Several other analysts also recently weighed in on INVA. Cantor Fitzgerald began coverage on Innoviva in a research report on Friday, July 11th. They issued an “overweight” rating and […] - 2025-09-02 03:06:54
Comparing Innoviva (NASDAQ:INVA) and Novo Nordisk A/S (NYSE:NVO)
Innoviva (NASDAQ:INVA – Get Free Report) and Novo Nordisk A/S (NYSE:NVO – Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, risk, profitability and earnings. Institutional & Insider Ownership 99.1% of Innoviva shares […] - 2025-09-01 03:01:00
Deutsche Bank AG Trims Stock Position in Innoviva, Inc. (NASDAQ:INVA)
Deutsche Bank AG decreased its position in shares of Innoviva, Inc. (NASDAQ:INVA – Free Report) by 4.2% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 827,730 shares of the biotechnology company’s stock after selling 36,549 shares during the quarter. Deutsche Bank AG owned approximately […] - 2025-08-15 05:51:00
Innoviva (NASDAQ:INVA) and AbbVie (NYSE:ABBV) Financial Comparison
Innoviva (NASDAQ:INVA – Get Free Report) and AbbVie (NYSE:ABBV – Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability and institutional ownership. Profitability This table compares Innoviva and AbbVie’s net margins, return […] - 2025-08-13 04:40:48
Innoviva (NASDAQ:INVA) Stock Price Up 8.2% on Analyst Upgrade
Innoviva, Inc. (NASDAQ:INVA – Get Free Report) shares were up 8.2% on Monday after HC Wainwright raised their price target on the stock from $40.00 to $45.00. HC Wainwright currently has a buy rating on the stock. Innoviva traded as high as $19.66 and last traded at $19.84. Approximately 205,104 shares traded hands during trading, […] - 2025-08-13 02:55:07
Innoviva (NASDAQ:INVA) and AbbVie (NYSE:ABBV) Head-To-Head Review
Innoviva (NASDAQ:INVA – Get Free Report) and AbbVie (NYSE:ABBV – Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations. Earnings & Valuation This table compares Innoviva and AbbVie”s gross […] - 2025-08-06 04:40:51
Principal Financial Group Inc. Grows Stock Position in Innoviva, Inc. (NASDAQ:INVA)
Principal Financial Group Inc. boosted its stake in Innoviva, Inc. (NASDAQ:INVA – Free Report) by 2.6% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 305,476 shares of the biotechnology company’s stock after acquiring an additional 7,700 shares during the quarter. […] - 2025-07-17 05:51:13
Innoviva (NASDAQ:INVA) vs. Merck & Co., Inc. (NYSE:MRK) Head to Head Comparison
Innoviva (NASDAQ:INVA – Get Free Report) and Merck & Co., Inc. (NYSE:MRK – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, earnings, dividends and institutional ownership. Earnings & Valuation This table compares Innoviva […] - 2025-07-17 04:38:50
New York State Teachers Retirement System Has $1.04 Million Holdings in Innoviva, Inc. (NASDAQ:INVA)
New York State Teachers Retirement System lessened its holdings in shares of Innoviva, Inc. (NASDAQ:INVA – Free Report) by 5.7% during the first quarter, Holdings Channel.com reports. The institutional investor owned 57,498 shares of the biotechnology company’s stock after selling 3,448 shares during the quarter. New York State Teachers Retirement System’s holdings in Innoviva were […] - 2025-07-10 04:59:01
Illinois Municipal Retirement Fund Reduces Stock Position in Innoviva, Inc. (NASDAQ:INVA)
Illinois Municipal Retirement Fund lowered its stake in Innoviva, Inc. (NASDAQ:INVA – Free Report) by 4.3% during the 1st quarter, HoldingsChannel reports. The firm owned 27,806 shares of the biotechnology company’s stock after selling 1,260 shares during the period. Illinois Municipal Retirement Fund’s holdings in Innoviva were worth $504,000 as of its most recent filing […] - 2025-07-04 04:46:49
Exchange Traded Concepts LLC Grows Stock Holdings in Innoviva, Inc. (NASDAQ:INVA)
Exchange Traded Concepts LLC grew its holdings in Innoviva, Inc. (NASDAQ:INVA – Free Report) by 8.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 176,025 shares of the biotechnology company’s stock after purchasing an additional 14,020 shares during the quarter. Exchange […] - 2025-06-17 06:15:01
FDA Grants Priority Review For Innoviva's Zoliflodacin For Treatment Of Uncomplicated Gonorrhea
(RTTNews) - Innoviva Specialty Therapeutics, Inc., a unit of Innoviva, Inc. (INVA), in partnership with the Global Antibiotic Research & Development Partnership (GARDP), Thursday said that the U.S. Food and Drug Administration (FDA) has granted Priority Review for the New Drug Ap - 2025-06-12 08:48:08
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Buys 1,162 Shares of Innoviva, Inc. (NASDAQ:INVA)
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Innoviva, Inc. (NASDAQ:INVA – Free Report) by 3.8% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 31,490 shares of the biotechnology company’s stock after acquiring an additional 1,162 shares […] - 2025-05-29 05:40:50
Two Sigma Investments LP Has $4.56 Million Stock Position in Innoviva, Inc. (NASDAQ:INVA)
Two Sigma Investments LP reduced its position in shares of Innoviva, Inc. (NASDAQ:INVA – Free Report) by 45.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 262,739 shares of the biotechnology company’s stock after selling 221,073 shares […] - 2025-05-28 05:20:52
10,612 Shares in Innoviva, Inc. (NASDAQ:INVA) Purchased by Cubist Systematic Strategies LLC
Cubist Systematic Strategies LLC purchased a new position in Innoviva, Inc. (NASDAQ:INVA – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 10,612 shares of the biotechnology company’s stock, valued at approximately $184,000. Other hedge funds and other institutional investors also […] - 2025-05-19 04:38:50
Sum Up The Parts: IJR Could Be Worth $128
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-15 07:40:06
MetLife Investment Management LLC Acquires 1,731 Shares of Innoviva, Inc. (NASDAQ:INVA)
MetLife Investment Management LLC raised its holdings in shares of Innoviva, Inc. (NASDAQ:INVA – Free Report) by 5.2% in the 4th quarter, Holdings Channel reports. The firm owned 34,961 shares of the biotechnology company’s stock after purchasing an additional 1,731 shares during the quarter. MetLife Investment Management LLC’s holdings in Innoviva were worth $607,000 at […] - 2025-05-05 05:30:51
Innoviva (NASDAQ:INVA) Upgraded by StockNews.com to “Buy” Rating
Innoviva (NASDAQ:INVA – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Wednesday. Separately, Scotiabank started coverage on shares of Innoviva in a report on Friday, March 7th. They issued a “sector outperform” rating and a $55.00 […] - 2025-05-02 02:46:47
Dimensional Fund Advisors LP Grows Position in Innoviva, Inc. (NASDAQ:INVA)
Dimensional Fund Advisors LP raised its position in Innoviva, Inc. (NASDAQ:INVA – Free Report) by 4.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,919,518 shares of the biotechnology company’s stock after buying an additional 226,592 shares during the […] - 2025-04-30 06:00:57
Look Under The Hood: IJR Has 39% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-14 09:05:39
Innoviva (NASDAQ:INVA) Downgraded to “Hold” Rating by StockNews.com
Innoviva (NASDAQ:INVA – Get Free Report) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued on Tuesday. Separately, Scotiabank started coverage on shares of Innoviva in a research report on Friday, March 7th. They set a “sector outperform” rating and a $55.00 target price […] - 2025-04-03 02:27:03
72,400 Shares in Innoviva, Inc. (NASDAQ:INVA) Acquired by KLP Kapitalforvaltning AS
KLP Kapitalforvaltning AS acquired a new stake in shares of Innoviva, Inc. (NASDAQ:INVA – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 72,400 shares of the biotechnology company’s stock, valued at approximately $1,256,000. KLP Kapitalforvaltning AS owned 0.12% of Innoviva as […] - 2025-03-30 06:16:54
Innoviva (NASDAQ:INVA) Upgraded by StockNews.com to “Buy” Rating
StockNews.com upgraded shares of Innoviva (NASDAQ:INVA – Free Report) from a hold rating to a buy rating in a research note published on Monday morning. Separately, Scotiabank began coverage on Innoviva in a research report on Friday, March 7th. They issued a “sector outperform” rating and a $55.00 target price on the stock. Read Our […] - 2025-03-25 04:09:01
Innoviva (NASDAQ:INVA) Upgraded at StockNews.com
StockNews.com upgraded shares of Innoviva (NASDAQ:INVA – Free Report) from a hold rating to a buy rating in a report released on Friday. Separately, Scotiabank started coverage on Innoviva in a research report on Friday. They set a “sector outperform” rating and a $55.00 price objective on the stock. Check Out Our Latest Analysis on […] - 2025-03-10 04:28:55
Scotiabank Begins Coverage on Innoviva (NASDAQ:INVA)
Scotiabank began coverage on shares of Innoviva (NASDAQ:INVA – Free Report) in a research report released on Friday morning, MarketBeat Ratings reports. The brokerage issued a sector outperform rating and a $55.00 target price on the biotechnology company’s stock. Separately, StockNews.com cut Innoviva from a “buy” rating to a “hold” rating in a research report […] - 2025-03-10 04:28:54
Illinois Municipal Retirement Fund Increases Holdings in Innoviva, Inc. (NASDAQ:INVA)
Illinois Municipal Retirement Fund increased its stake in Innoviva, Inc. (NASDAQ:INVA – Free Report) by 2.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 29,066 shares of the biotechnology company’s stock after acquiring an additional 784 shares during […] - 2025-03-05 08:41:50

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc INVA holdings

DateNumber of INVA Shares HeldBase Market Value of INVA SharesLocal Market Value of INVA SharesChange in INVA Shares HeldChange in INVA Base ValueCurrent Price per INVA Share HeldPrevious Price per INVA Share Held
2025-12-11 (Thursday)5,914USD 121,947USD 121,9470USD 0 USD 20.6201 USD 20.6201
2025-12-10 (Wednesday)5,914USD 121,947INVA holding decreased by -532USD 121,9470USD -532 USD 20.6201 USD 20.71
2025-12-09 (Tuesday)5,914USD 122,479INVA holding decreased by -1715USD 122,4790USD -1,715 USD 20.71 USD 21
2025-12-08 (Monday)5,914USD 124,194INVA holding increased by 1538USD 124,1940USD 1,538 USD 21 USD 20.7399
2025-12-05 (Friday)5,914USD 122,656INVA holding decreased by -355USD 122,6560USD -355 USD 20.7399 USD 20.8
2025-12-04 (Thursday)5,914USD 123,011INVA holding decreased by -355USD 123,0110USD -355 USD 20.8 USD 20.86
2025-12-03 (Wednesday)5,914INVA holding decreased by -100USD 123,366INVA holding decreased by -2808USD 123,366-100USD -2,808 USD 20.86 USD 20.98
2025-12-02 (Tuesday)6,014INVA holding increased by 40USD 126,174INVA holding decreased by -236USD 126,17440USD -236 USD 20.98 USD 21.16
2025-12-01 (Monday)5,974USD 126,410INVA holding decreased by -3405USD 126,4100USD -3,405 USD 21.16 USD 21.73
2025-11-28 (Friday)5,974USD 129,815INVA holding increased by 119USD 129,8150USD 119 USD 21.73 USD 21.7101
2025-11-27 (Thursday)5,974USD 129,696USD 129,6960USD 0 USD 21.7101 USD 21.7101
2025-11-26 (Wednesday)5,974USD 129,696INVA holding decreased by -59USD 129,6960USD -59 USD 21.7101 USD 21.72
2025-11-25 (Tuesday)5,974INVA holding decreased by -60USD 129,755INVA holding increased by 1291USD 129,755-60USD 1,291 USD 21.72 USD 21.29
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of INVA by Blackrock for IE00B3VWM098

Show aggregate share trades of INVA

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-03SELL-10021.20020.840 20.876USD -2,088 19.03 Loss of -185 on sale
2025-12-02BUY4021.31020.640 20.707USD 828 19.02
2025-11-25SELL-6021.84021.200 21.264USD -1,276 18.96 Loss of -138 on sale
2025-11-24SELL-6021.49020.960 21.013USD -1,261 18.95 Loss of -124 on sale
2025-11-17SELL-22022.51021.960 22.015USD -4,843 18.88 Loss of -689 on sale
2025-11-12SELL-2022.45521.690 21.767USD -435 18.83 Loss of -59 on sale
2025-11-06SELL-2020.90018.850 19.055USD -381 18.79 Loss of -5 on sale
2025-11-05SELL-20018.31517.870 17.915USD -3,583 18.79 Profit of 175 on sale
2025-11-04SELL-4018.30017.910 17.949USD -718 18.79 Profit of 34 on sale
2025-11-03SELL-4018.28517.860 17.903USD -716 18.80 Profit of 36 on sale
2025-10-28BUY6017.69017.900 17.879USD 1,073 18.82
2025-10-24SELL-2017.71018.450 18.376USD -368 18.83 Profit of 9 on sale
2025-10-15BUY12017.39017.480 17.471USD 2,097 18.88
2025-10-02BUY2017.66018.090 18.047USD 361 18.89
2025-09-30BUY4018.25018.580 18.547USD 742 18.90
2025-08-21SELL-2019.97020.260 20.231USD -405 18.89 Loss of -27 on sale
2025-07-31BUY6018.17018.510 18.476USD 1,109 18.89
2025-06-30SELL-4020.09020.270 20.252USD -810 18.83 Loss of -57 on sale
2025-06-25SELL-2020.48020.840 20.804USD -416 18.80 Loss of -40 on sale
2025-06-20SELL-4021.00021.590 21.531USD -861 18.76 Loss of -111 on sale
2025-05-23BUY2018.97019.100 19.087USD 382 18.44
2025-05-19SELL-2018.63018.750 18.738USD -375 18.43 Loss of -6 on sale
2025-05-15SELL-6018.33018.560 18.537USD -1,112 18.43 Loss of -6 on sale
2025-05-12SELL-2018.61018.720 18.709USD -374 18.43 Loss of -6 on sale
2025-05-09SELL-2018.56018.670 18.659USD -373 18.43 Loss of -5 on sale
2025-04-30SELL-2018.69018.780 18.771USD -375 18.41 Loss of -7 on sale
2025-04-24SELL-4018.38018.570 18.551USD -742 18.42 Loss of -5 on sale
2025-04-17SELL-2018.27018.370 18.360USD -367 18.42 Profit of 1 on sale
2025-04-15SELL-6018.11018.280 18.263USD -1,096 18.43 Profit of 10 on sale
2025-04-14SELL-6017.98018.060 18.052USD -1,083 18.43 Profit of 23 on sale
2025-04-09SELL-8017.32017.650 17.617USD -1,409 18.47 Profit of 68 on sale
2025-04-07SELL-14017.51017.840 17.807USD -2,493 18.50 Profit of 96 on sale
2025-04-04SELL-20017.72018.030 17.999USD -3,600 18.50 Profit of 101 on sale
2025-03-31BUY2018.13018.270 18.256USD 365 18.52
2025-03-19SELL-4017.29017.350 17.344USD -694 18.63 Profit of 51 on sale
2025-03-14SELL-12017.39017.520 17.507USD -2,101 18.68 Profit of 141 on sale
2025-03-13SELL-4017.39017.450 17.444USD -698 18.70 Profit of 50 on sale
2025-03-12SELL-68017.41017.640 17.617USD -11,980 18.72 Profit of 749 on sale
2025-03-07SELL-4017.64017.850 17.829USD -713 18.77 Profit of 38 on sale
2025-03-06SELL-6017.59017.640 17.635USD -1,058 18.79 Profit of 69 on sale
2025-03-03SELL-2017.79017.910 17.898USD -358 18.84 Profit of 19 on sale
2025-02-28SELL-12017.92017.990 17.983USD -2,158 18.86 Profit of 105 on sale
2025-02-26SELL-2017.90018.090 18.071USD -361 18.89 Profit of 16 on sale
2025-02-25SELL-6018.03018.260 18.237USD -1,094 18.91 Profit of 40 on sale
2025-02-18BUY10018.03018.140 18.129USD 1,813 19.00
2025-02-13BUY2018.22018.330 18.319USD 366 19.06
2025-02-12BUY2017.98018.050 18.043USD 361 19.08
2025-02-11BUY6018.06018.080 18.078USD 1,085 19.10
2025-02-06BUY18018.26018.390 18.377USD 3,308 19.15
2025-01-27BUY2018.98019.390 19.349USD 387 19.26
2024-12-30BUY10017.38017.530 17.515USD 1,752 19.42
2024-12-06BUY8019.05019.180 19.167USD 1,533 19.45
2024-12-05BUY2018.92018.980 18.974USD 379 19.47
2024-12-04BUY10018.87019.100 19.077USD 1,908 19.49
2024-11-29BUY10018.99019.180 19.161USD 1,916 19.54
2024-11-27BUY8019.05019.200 19.185USD 1,535 19.59
2024-11-26BUY2019.14019.240 19.230USD 385 19.61
2024-11-21BUY10019.06019.300 19.276USD 1,928 19.68
2024-11-20BUY6019.15019.220 19.213USD 1,153 19.71
2024-11-18BUY24018.95019.190 19.166USD 4,600 19.80
2024-11-12BUY16020.32021.280 21.184USD 3,389 19.76
2024-11-08BUY10020.18020.320 20.306USD 2,031 19.73
2024-11-07BUY30020.00020.270 20.243USD 6,073 19.71
2024-11-06BUY4019.92020.290 20.253USD 810 19.70
2024-10-31BUY2019.56019.720 19.704USD 394 19.84
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of INVA

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1965,9300149,25444.2%
2025-09-1854,6800119,64845.7%
2025-09-1740,834095,18142.9%
2025-09-16227,90828,600465,82048.9%
2025-09-1585,0100176,81948.1%
2025-09-12156,615104,900229,85868.1%
2025-09-11146,7540312,18647.0%
2025-09-1075,3030156,34248.2%
2025-09-0994,4285,671191,25749.4%
2025-09-0877,5210154,07250.3%
2025-09-0588,6700245,18336.2%
2025-09-0486,5260170,26750.8%
2025-09-0348,464194153,63031.5%
2025-09-02119,9720249,50448.1%
2025-08-2991,2650190,46547.9%
2025-08-2848,8950140,29934.9%
2025-08-27107,25332,800194,10755.3%
2025-08-2623,5320145,16016.2%
2025-08-2551,1670168,30630.4%
2025-08-2235,4250126,65628.0%
2025-08-2125,225200118,57821.3%
2025-08-2023,281590143,01816.3%
2025-08-1916,7310109,94915.2%
2025-08-18190,9920438,04143.6%
2025-08-1562,2760302,38920.6%
2025-08-1456,5150301,29418.8%
2025-08-13126,56739384,53032.9%
2025-08-12221,544187351,90963.0%
2025-08-11368,0990589,10062.5%
2025-08-08108,8600228,59747.6%
2025-08-07220,464600484,31945.5%
2025-08-0665,7252279,15023.5%
2025-08-0542,1310166,65125.3%
2025-08-0451,72414196,34726.3%
2025-08-01150,4000358,92441.9%
2025-07-3148,4820193,49925.1%
2025-07-3027,1180151,61717.9%
2025-07-2929,8650121,24024.6%
2025-07-28121,9740302,76940.3%
2025-07-25130,8500367,27435.6%
2025-07-2430,1901218,54313.8%
2025-07-2343,3520213,25620.3%
2025-07-2222,737789211,77510.7%
2025-07-2134,6270151,49622.9%
2025-07-1842,8590211,82120.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy